Politico December 11, 2024
POLICY PUZZLE
The Food and Drug Administration needs more artificial intelligence talent to regulate the technology, according to Kev Coleman, a research fellow at the Paragon Health Institute, a think tank founded by a former adviser to President-elect Donald Trump.
In a new report, Coleman laid out a policy agenda for how AI should be regulated in health care. First, he said, no policy should interfere with “the primacy” of the FDA’s medical software safety-evaluation process. That would help avoid regulatory capture, he noted. Second, new policies should ensure they incentivize companies to fix problems with their technology.
Coleman also said policymakers should avoid broad AI legislation because not all AI is the same. For example, generative AI poses different...
Today's Sponsors
Today's Sponsor